Jens Præstgaard

机构：Novartis (Switzerland), Novartis Institutes for BioMedical Research · ORCID：0000-0001-5122-7190

发表论文 64 篇 · 总被引 3748 次 · h-index 24

代表论文

• Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity (2021 · JAMA Network Open · 被引 329)
• Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults (2020 · JAMA Network Open · 被引 172)
• Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement (2020 · Annals of Internal Medicine · 被引 170)
• Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device (2024 · Scientific Reports · 被引 79)
• Continuous Digital Monitoring of Walking Speed in Frail Elderly Patients: Noninterventional Validation Study and Longitudinal Clinical Trial (2019 · JMIR mhealth and uhealth · 被引 64)
• Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort (2020 · Journal of Cachexia Sarcopenia and Muscle · 被引 53)